Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Medical Teacher|February 28, 2012
Student perspectives on assessment: experience in a competency-based portfolio systemFaysal Altahawi, Bryan Sisk, Stacey Poloskey, et al.Blood Advances|November 18, 2021
Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose studyToshko Lissitchkov, Annemieke Willemze, Suresh Katragadda, et al.Lancet (London, England)|April 1, 2023
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trialGuy Young, Alok Srivastava, Kaan Kavakli, et al.The New England Journal of Medicine|September 9, 2020
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia ABarbara A Konkle, Amy D Shapiro, Doris V Quon, et al.The New England Journal of Medicine|January 31, 2023
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia AAnnette von Drygalski, Pratima Chowdary, Roshni Kulkarni, et al.The Lancet. Haematology|April 1, 2023
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trialAlok Srivastava, Savita Rangarajan, Kaan Kavakli, et al.Pageof 1